Unknown

Dataset Information

0

NIR-Cyanine Dye Linker: a Promising Candidate for Isochronic Fluorescence Imaging in Molecular Cancer Diagnostics and Therapy Monitoring.


ABSTRACT: Personalized anti-cancer medicine is boosted by the recent development of molecular diagnostics and molecularly targeted drugs requiring rapid and efficient ligation routes. Here, we present a novel approach to synthetize a conjugate able to act simultaneously as an imaging and as a chemotherapeutic agent by coupling functional peptides employing solid phase peptide synthesis technologies. Development and the first synthesis of a fluorescent dye with similarity in the polymethine part of the Cy7 molecule whose indolenine-N residues were substituted with a propylene linker are described. Methylating agent temozolomide is functionalized with a tetrazine as a diene component whereas Cy7-cell penetrating peptide conjugate acts as a dienophilic reaction partner for the inverse Diels-Alder click chemistry-mediated ligation route yielding a theranostic conjugate, 3-mercapto-propionic-cyclohexenyl-Cy7-bis-temozolomide-bromide-cell penetrating peptide. Synthesis route described here may facilitate targeted delivery of the therapeutic compound to achieve sufficient local concentrations at the target site or tissue. Its versatility allows a choice of adequate imaging tags applicable in e.g. PET, SPECT, CT, near-infrared imaging, and therapeutic substances including cytotoxic agents. Imaging tags and therapeutics may be simultaneously bound to the conjugate applying click chemistry. Theranostic compound presented here offers a solid basis for a further improvement of cancer management in a precise, patient-specific manner.

SUBMITTER: Komljenovic D 

PROVIDER: S-EPMC4679360 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

NIR-Cyanine Dye Linker: a Promising Candidate for Isochronic Fluorescence Imaging in Molecular Cancer Diagnostics and Therapy Monitoring.

Komljenovic Dorde D   Wiessler Manfred M   Waldeck Waldemar W   Ehemann Volker V   Pipkorn Ruediger R   Schrenk Hans-Hermann HH   Debus Jürgen J   Braun Klaus K  

Theranostics 20160101 1


Personalized anti-cancer medicine is boosted by the recent development of molecular diagnostics and molecularly targeted drugs requiring rapid and efficient ligation routes. Here, we present a novel approach to synthetize a conjugate able to act simultaneously as an imaging and as a chemotherapeutic agent by coupling functional peptides employing solid phase peptide synthesis technologies. Development and the first synthesis of a fluorescent dye with similarity in the polymethine part of the Cy7  ...[more]

Similar Datasets

| S-EPMC4134706 | biostudies-other
| S-EPMC6744268 | biostudies-literature
| S-EPMC2871283 | biostudies-literature
| S-EPMC4172377 | biostudies-literature
| S-EPMC3544408 | biostudies-literature
| S-EPMC5500852 | biostudies-other
| S-EPMC8582267 | biostudies-literature
| S-EPMC5858757 | biostudies-other
| S-EPMC6160486 | biostudies-other
| S-EPMC6817597 | biostudies-literature